About
Looking for more information?
Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
INVESTOR PRESENTATION - Regeneus Ltd
Regeneus Ltd
Health
Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.
Read moreMarket Cap
$36.03m
Price at Close
$0.12
4w avg. Volume
160.59k
4w avg. Turnover
$19.29k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| +9.09% | 19 Nov 2020 |
| +9.09% | 19 Nov 2020 |
| +9.09% | 19 Nov 2020 |
| +9.09% | 19 Nov 2020 |
| +9.09% | 19 Nov 2020 |
| -4.17% | 10 Nov 2020 |
| -8.00% | 02 Nov 2020 |
| -8.00% | 01 Nov 2020 |
| -11.11% | 30 Oct 2020 |
| -11.11% | 30 Oct 2020 |
Market Data
Current Price
$0.12
52WK HIGH
$0.2
52WK LOW
$0.049
1YR RETURN
+64.47%
1YR RETURN VS. SECTOR
+26.96%
90 DAY RETURN
-10.71%
ASX RANK
1,285
/2,047
SECTOR RANK
121
/168
SHARES OUTSTANDING
300.28m
Regeneus Ltd
Health
Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.
Read moreMarket Cap
$36.03m
Price at Close
$0.12
4w avg. Volume
160.59k
4w avg. Turnover
$19.29k
ASX:RGS is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia